Research chemical — not approvedaka Prohibitin-TP01

Adipotide — Profile & Reference (2026)

Last updated 2026-06-30

Adipotide (also known as Prohibitin-TP01) is a peptide catalogued under Weight Loss & Metabolic (Pro-apoptotic peptide). It is described as: Prohibitin (adipose vasculature). Documented context: Obesity (preclinical). Neutral reference entry; EU status: not approved for human use (research use only).

Mechanism / target

Prohibitin (adipose vasculature).

Documented context

Reported research or therapeutic context: Obesity (preclinical). This is neutral reference information, not a usage recommendation or medical advice.

Source: en.wikipedia.org ↗

Full sourced guide in progress

We publish a complete, primary-source-cited guide only once we can verify at least five PubMed/clinical references. This profile is intentionally a concise, sourced reference entry until then — we do not pad pages with unverified citations. The quick facts and source link above reflect what we can state reliably today.

This article is for educational and research purposes only. Peptides discussed here are not approved for human consumption by the FDA, EMA, or equivalent regulators outside of specific clinical contexts. Always consult a licensed medical professional before any therapeutic use.